Ignite Creation Date:
2025-12-24 @ 5:57 PM
Ignite Modification Date:
2026-01-04 @ 2:01 PM
Study NCT ID:
NCT04034368
Status:
UNKNOWN
Last Update Posted:
2019-07-26
First Post:
2019-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir
Sponsor:
The First Hospital of Jilin University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-06
Completion Date Type:
ESTIMATED
First Submit Date:
2019-07-24
First Submit QC Date:
None
Study First Post Date:
2019-07-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-24
Last Update Post Date:
2019-07-26
Last Update Post Date Type:
ACTUAL